about
Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes.Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism.Centrizonal arteries and microvessels in nonalcoholic steatohepatitis.Loss of PDGF-B activity increases hepatic vascular permeability and enhances insulin sensitivity.Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression.Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide.Computational Modeling in Liver Surgery.
P2860
Q33937311-A08B2054-B0F7-4F46-9923-4EB3D3F4E8A3Q34237602-4D91DE61-8D5E-4E27-BB8D-585BA3FE78B5Q35165370-906A4A5A-6659-4399-B7B2-74999DD405AEQ35216708-2E799245-3D9B-4480-90D5-1ECE742B0472Q40691956-8B208A36-89F6-449D-B83D-3DFB1CA409EFQ42138775-D905043D-E489-40B8-9CEA-2AA174BBB097Q47145823-A2959BA5-8405-4F70-B1D9-518F089BF891
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Obesity, insulin resistance and hepatic perfusion.
@en
type
label
Obesity, insulin resistance and hepatic perfusion.
@en
prefLabel
Obesity, insulin resistance and hepatic perfusion.
@en
P1433
P1476
Obesity, insulin resistance and hepatic perfusion.
@en
P2093
Robert B Dorman
Robert W Brock
P304
P356
10.1080/10739680701282986
P577
2007-06-01T00:00:00Z